Developing an oral Covid-19 vaccine
Israel’s Oramed (reported here previously) has launched Oravax – a joint venture with India’s Premas Biotech to develop a Covid-19 vaccine. The vaccine is administered orally (not injected) and targets 3 virus proteins, so should counter any mutations. Human trials expected soon.
This entry was posted in Israel's Medical Achievements
. Bookmark the permalink